Our Products

Stramsen Biotech Inc., a pioneering Texas-based biopharmaceutical company, is revolutionizing patient care through innovative, plant-based medicines. With a long-term commitment to the biopharmaceutical industry, Stramsen Biotech leverages its proprietary database of several thousand medicinal plants to spearhead natural approaches to drug development. Our robust pipeline currently includes 33 drug candidates at various stages of development, with 11 candidates poised for clinical trials. Some of these groundbreaking treatments are already in limited use overseas, demonstrating our global reach and potential.

The significance of our work is underscored by the global pharmaceutical landscape, where over 40% of all prescribed medicines worldwide are derived from medicinal plants. These plant-based drugs undergo rigorous clinical trials to ensure safety and efficacy, aligning with our commitment to addressing critical health challenges through nature-inspired solutions.

Our exceptional team comprises distinguished researchers and scientists from the Houston, Texas area, dedicated to exploring the scientific mechanisms underlying modern medicine. With over a century of combined experience in pharmaceutical-related research, our staff includes PhD-level scientists and university professors specializing in chemistry, medicine, and biotechnology. Team members have garnered numerous awards and grants for their groundbreaking research projects, with publications available upon request, showcasing our commitment to scientific excellence and innovation.

Key Drug Candidates in Development:

SBX 1052: Controls and prevents prostate gland enlargement
SBX 1968: Controls and prevents proliferation and metastasis of prostate cancer
SBX 2021: Controls and prevents proliferation and metastasis of various cancer cells
SBX 2022: Controls and prevents proliferation and metastasis of blood cancer
SBX 2023: Treats various forms of peripheral neuropathic disorders
SBX 2000: Manages various forms of cardiovascular diseases
SBX 1977: Wound healing drug with cell proliferation and strong antibacterial properties
SBX 2048: Controls HIV and improves immunity
SBX 1988: Controls diabetes
SBX 2011: Treats kidney infections and dissolves/breaks up gallstones
SBX 1967: Relieves bone/joint pains, treats bone/joint infections, improves joint lubrication

Additional Drug Candidates (SBRX Series):

SBRX2: Controls fever, flu, allergy, and viral respiratory infections
SBRX3: Promotes insulin production for diabetes control
SBRX4: Treats gout and joint pains
SBRX5: Controls HIV infection and enhances immunity
SBRX6: Controls asthma, allergies, and other respiratory conditions
SBRX7: Treats ulcers, heartburn, and indigestion
SBRX8: Prevents and controls sickle cell disease
SBRX9: Addresses attention deficit disorders/hyperactivity disorder, improves attention and memory
SBRX10: Relieves constipation
SBRX11: Treats resistant malaria, intermittent fevers, malaise, and lethargy
SBRX12: Controls gastric acid, heartburn, and stomach ulcers; protects gastric lining; eliminates ulcer-causing bacteria
SBRX13: Promotes sperm development and maturation, testosterone production, and improves erectile function
SBRX14: Promotes androgen production, sperm development, and maturation
SBRX15: Treats urogenital tract infections, controlling bacteria, viruses, protozoa, and fungi
SBRX16: Controls neurological disorders and epilepsy
SBRX17: Manages dysmenorrhea (painful menstrual cramps)
SBRX18: Controls uterine fibroids and promotes female hormone balance
SBRX19: Controls flu and fever, relieves asthma and cough
SBRX20: Controls hepatitis viruses (A, B, C, D, E, G), treats yellow fever and other fever-causing viruses
SBRX21: Relieves pain associated with inguinal hernia in men
SBRX22: Relieves pain associated with ovulation disorders in women

Stramsen Biotech Inc. is dedicated to advancing these innovative therapies through our rigorous research and development process. Our ultimate goal is to bring transformative, plant-based treatments to patients worldwide, addressing a wide range of medical conditions and improving global health outcomes. By harnessing the power of nature and combining it with cutting-edge scientific expertise, we are poised to make significant contributions to the biopharmaceutical industry and revolutionize patient care for years to come.